Because elevated inflammatory cytokines in obesity can accelerate the expression and secretion of apelin, it is hypothesized that downregulation of apelin in obese diabetic rats treated with LC may be associated with the anti‐inflammatory action of LC. The gene discussed is APLN; the disease is obesity due to melanocortin 4 receptor deficiency.